The appeal of fruit preparations lies in their ability to provide consistent flavor, color, and texture throughout the year. Since fresh fruit availability can vary depending on season and location, fruit preparations help manufacturers maintain product uniformity while incorporating fruit-based ingredients into their offerings.
Hernia repair isn't just about placing a mesh – it's about keeping it there securely, safely, and with minimal long-term discomfort. The choice of fixation device matters more than you might think.
HISTORY / ORIGIN
The journey of hernia repair is a story of continuous innovation. The first surgical inguinal hernia repair was reported as early as 1716. However, the modern era began in 1958 when Usher performed the first mesh repair. He introduced the first polypropylene mesh in 1968 as a method to achieve tension‑free hernia repair. The term "tension‑free" hernioplasty was later popularized by Lichtenstein and colleagues in 1986.
But a mesh alone isn't enough – it needs to be fixed in place. Tack fixation has been applied since the introduction of laparoscopic inguinal and ventral hernia repair in the late 1980s and early 1990s. Initially, surgeons used permanent metallic tacks. Over time, concerns about chronic pain and…
Lung cancer kills more people than colon, breast, and prostate cancer combined. But what if a computer could spot it years before you felt a thing – and with remarkable accuracy?
HISTORY / ORIGIN
For decades, lung cancer screening relied on the naked eye and a radiologist's expertise. Low-dose CT (LDCT) scans became the standard, but interpreting them was time‑consuming and prone to human error. The game changed in the early 2020s when AI-powered software began entering clinical practice. The FDA cleared several AI programs for lung cancer screening, and in February 2026, a major milestone was reached: the FDA granted 510(k) clearance to eyonis® LCS, the first end‑to‑end AI device that both detects and characterizes lung cancer in a single product. Today, the global lung cancer screening software market is projected to grow at nearly 18% annually through 2031, driven by advancements in artificial intelligence and rising health awareness.
